[go: up one dir, main page]

MXPA03010684A - Peptidos y el uso de los mismos para oscurecer la piel. - Google Patents

Peptidos y el uso de los mismos para oscurecer la piel.

Info

Publication number
MXPA03010684A
MXPA03010684A MXPA03010684A MXPA03010684A MXPA03010684A MX PA03010684 A MXPA03010684 A MX PA03010684A MX PA03010684 A MXPA03010684 A MX PA03010684A MX PA03010684 A MXPA03010684 A MX PA03010684A MX PA03010684 A MXPA03010684 A MX PA03010684A
Authority
MX
Mexico
Prior art keywords
darkening
peptides
skin
present
compositions containing
Prior art date
Application number
MXPA03010684A
Other languages
English (en)
Inventor
Seiberg Miri
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA03010684A publication Critical patent/MXPA03010684A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se refiere a peptidos, composiciones que contienen a estos peptidos, y al uso de los mismos para oscurecer la piel.
MXPA03010684A 2001-05-21 2002-05-24 Peptidos y el uso de los mismos para oscurecer la piel. MXPA03010684A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/862,145 US7214655B2 (en) 2001-05-21 2001-05-21 Peptides and the use thereof in darkening the skin
PCT/US2002/016734 WO2003099841A2 (en) 2001-05-21 2002-05-24 Peptides and the use thereof in darkening the skin

Publications (1)

Publication Number Publication Date
MXPA03010684A true MXPA03010684A (es) 2005-11-04

Family

ID=32072628

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010684A MXPA03010684A (es) 2001-05-21 2002-05-24 Peptidos y el uso de los mismos para oscurecer la piel.

Country Status (7)

Country Link
US (1) US7214655B2 (es)
EP (1) EP1578769A4 (es)
AU (2) AU2002257328A1 (es)
BR (1) BR0211186A (es)
CA (1) CA2448169C (es)
MX (1) MXPA03010684A (es)
WO (1) WO2003099841A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213286D0 (en) * 2002-06-10 2002-07-24 Univ Edinburgh Par-2-Activating peptide derivative and pharmaceutical composition using the same
CA2490129A1 (en) * 2002-06-26 2004-01-08 Entremed, Inc. Compositions and methods comprising protein activated receptor antagonists
JP2008510726A (ja) * 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US7381707B2 (en) * 2005-06-30 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Treatment of dry eye
EP2011471A1 (en) * 2007-07-02 2009-01-07 Johnson & Johnson Consumer France SAS Foaming oil compositions
WO2009005151A1 (ja) * 2007-07-05 2009-01-08 Nissan Chemical Industries, Ltd. 新規脂質ペプチド並びにヒドロゲル
US20100135944A1 (en) 2008-12-01 2010-06-03 Nannan Chen Methods for darkening the skin and/or hair
US20100158826A1 (en) 2008-12-19 2010-06-24 Rudy Clemente Compositions comprising self-tanning agents and sugar amines
US20100158827A1 (en) * 2008-12-19 2010-06-24 Rudy Clemente Compositions comprising self-tanning agents and plant extracts
US20100158833A1 (en) * 2008-12-19 2010-06-24 Rudy Clemente Compositions comprising self-tanning agents and plant extracts
US20110081305A1 (en) * 2009-10-02 2011-04-07 Steven Cochran Compositions comprising a skin-lightening resorcinol and a skin darkening agent
US8084504B2 (en) 2009-10-02 2011-12-27 Johnson & Johnson Consumer Companies, Inc. High-clarity aqueous concentrates of 4-hexylresorcinol
US8906432B2 (en) 2009-10-02 2014-12-09 Johnson & Johnson Consumer Companies, Inc. Compositions comprising an NFκB-inhibitor and a non-retinoid collagen promoter
US20110081430A1 (en) 2009-10-02 2011-04-07 Simarna Kaur COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER
US20140086859A1 (en) 2012-09-24 2014-03-27 Johnson & Johnson Consumer Companies, Inc. Low oil compositions comprising a 4-substituted resorcinol and a high carbon chain ester
EP3218507B1 (en) * 2014-11-14 2020-01-08 The General Hospital Corporation Methods and compositions for enhancing skin pigmentation
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
GB1541463A (en) 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US4960764A (en) 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
US5227459A (en) 1990-05-18 1993-07-13 Yale University Synthetic melanin
US5216116A (en) 1990-05-18 1993-06-01 Yale University Soluble melanin
US5225435A (en) 1990-05-18 1993-07-06 Yale University Soluble melanin
US5218079A (en) 1990-05-18 1993-06-08 Yale University Soluble melanin
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US6043212A (en) 1993-07-26 2000-03-28 Cor Therapeutics, Inc. Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
US5744125A (en) 1993-08-19 1998-04-28 Yale University Cosmetic melanins
EP0870198A4 (en) * 1995-01-25 2001-04-04 Cor Therapeutics Inc RECOMBINANT C140 RECEPTOR, ITS AGONISTS AND ANTAGONISTS, AND NUCLEIC ACIDS ENCODING THE RECEPTOR
KR19980703668A (ko) 1995-04-03 1998-12-05 콜비 안드라 엘 레티노이드와 리포좀을 함유하는 피부 보호용 조성물
GB9801191D0 (en) 1998-01-20 1998-03-18 Unilever Plc Skin and hair darkening composition
US6323219B1 (en) * 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
FR2783169B1 (fr) 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
AU2003220567A1 (en) * 2002-03-28 2003-10-13 Johnson And Johnson Consumer Companies, Inc. Compostions for darkening the skin
AR070911A1 (es) * 2008-03-19 2010-05-12 Regeneron Pharma Uso de antagonistas del receptor par2 activado con proteasa

Also Published As

Publication number Publication date
CA2448169A1 (en) 2002-11-21
US7214655B2 (en) 2007-05-08
BR0211186A (pt) 2007-01-30
US20030138388A1 (en) 2003-07-24
AU2009217391A1 (en) 2009-10-15
EP1578769A2 (en) 2005-09-28
WO2003099841A2 (en) 2003-12-04
AU2002257328A1 (en) 2003-12-12
CA2448169C (en) 2011-07-19
WO2003099841A9 (en) 2010-07-22
EP1578769A4 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
YU68002A (sh) Modifikovani faktor viii
HUP0103265A3 (en) Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
DE69905170D1 (en) Thiazolopyrimidinderivate
DE60120712D1 (en) Kallikrein gen
AU2003294785A1 (en) Hair treatment compositions
AU2002365396A8 (en) Peptides, peptide compositions,and methods of use in binding p 185
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
MXPA03006629A (es) Composicion para el cuidado de la piel.
MXPA03010683A (es) Composicion que contiene un peptido y un pigmento y el uso del mismo para oscurecer la piel.
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
WO2004019965A3 (en) Thymus-based tolerogenic approaches for type i diabetes.
SG185137A1 (en) Biologically active peptides
EP1489093A4 (en) PEPTIDES, MEDICAL COMPOSITIONS CONTAINING PEPTIDES, AND MEDICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
MXPA05012742A (es) Composiciones de tratamiento para el cabello.
MXPA04002103A (es) Una proteina de union a caspasa-8, su preparacion y uso.
IL173929A (en) Kahlalid F analogs and their pharmacy preparations
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
AU2002257882A1 (en) Antibacterial peptides, compositions containing same and uses thereof
WO2002066513A3 (de) Humane zirkulierende lekti fragmente hf7072, hf7638 und hf14448 sowie ihre verwendung
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
MXPA04005226A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.

Legal Events

Date Code Title Description
FG Grant or registration